Cargando…

Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration

(1) Background: The aim of the present pilot study was to study the effect of a new oral gonadotropin-releasing hormone antagonist on adenomyosis. (2) Methods: Eight premenopausal women, aged between 37 and 45 years, presenting with heavy menstrual bleeding, pelvic pain, and dysmenorrhea due to diff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donnez, Jacques, Donnez, Olivier, Tourniaire, Jean, Brethous, Michel, Bestel, Elke, Garner, Elizabeth, Charpentier, Sébastien, Humberstone, Andrew, Loumaye, Ernest
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706704/ https://www.ncbi.nlm.nih.gov/pubmed/34945090 http://dx.doi.org/10.3390/jcm10245794

Ejemplares similares

Profile of Linzagolix in the Management of Endometriosis, Including Design, Development and Potential Place in Therapy: A Narrative Review
por: Donnez, Jacques, et al.
Publicado: (2023)

Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists
por: Donnez, Jacques, et al.
Publicado: (2021)

Conservative Management of Uterine Adenomyosis: Medical vs. Surgical Approach
por: Stratopoulou, Christina Anna, et al.
Publicado: (2021)

Linzagolix: First Approval
por: Keam, Susan J.
Publicado: (2022)

Identifying Common Pathogenic Features in Deep Endometriotic Nodules and Uterine Adenomyosis
por: Stratopoulou, Christina Anna, et al.
Publicado: (2021)

Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
por: Donnez, Jacques, et al.
Publicado: (2021)

GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?
por: Donnez, Jacques, et al.
Publicado: (2021)

Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review
por: Donnez, Jacques
Publicado: (2020)

Uterine fibroid management: from the present to the future
por: Donnez, Jacques, et al.
Publicado: (2016)

Conservative Management of Rectovaginal Deep Endometriosis: Shaving Should Be Considered as the Primary Surgical Approach in a High Majority of Cases
por: Donnez, Olivier
Publicado: (2021)

Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes
por: Dolmans, Marie-Madeleine, et al.
Publicado: (2014)

Conservative Management of Uterine Fibroid-Related Heavy Menstrual Bleeding and Infertility: Time for a Deeper Mechanistic Understanding and an Individualized Approach
por: Dolmans, Marie-Madeleine, et al.
Publicado: (2021)

Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options
por: Donnez, Jacques, et al.
Publicado: (2022)

SARS hits hard
por: Clarke, Tom
Publicado: (2003)

A Hard Hit
Publicado: (1857)

Emerging Drug Targets for Endometriosis
por: Dolmans, Marie-Madeleine, et al.
Publicado: (2022)

Comparison of Two Regimens of Gonadotropin-releasing Hormone Antagonists in Clomiphene-gonadotropin Induced Controlled Ovulation and Intrauterine Insemination Cycles: Randomized Controlled Study
por: Karthik, Sajja Devendra Siva, et al.
Publicado: (2018)

Whole Ovary Cryopreservation and Transplantation: A Systematic Review of Challenges and Research Developments in Animal Experiments and Humans
por: Hossay, Camille, et al.
Publicado: (2020)

Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?
por: Cacciottola, Luciana, et al.
Publicado: (2021)

DDoS attacks hit hard and fast
Publicado: (2020)

Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
por: Hassoun, Paul M., et al.
Publicado: (2021)

Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of Adenomyosis
por: Zhang, Peihai, et al.
Publicado: (2013)

Myxoma of the Ovary: in Regard to Bedir et al. (Balkan Med J 2018;35:120-121)
por: Sterkers, Nicolas, et al.
Publicado: (2019)

Angle of Uterine Flexion and Adenomyosis
por: Xholli, Anjeza, et al.
Publicado: (2022)

Use of mesenchymal stem cells to enhance or restore fertility potential: a systematic review of available experimental strategies
por: Cacciottola, L, et al.
Publicado: (2023)

Development of a New Negative Obstacle Sensor for Augmented Electric Wheelchair
por: Favey, Clément, et al.
Publicado: (2021)

Hit hard and early: Can the march of psoriasis be halted?
por: Jandhyala, Sridhar
Publicado: (2013)

COVID-19 has hit nursing homes hard
por: Pitkälä, Kaisu H.
Publicado: (2020)

Patients with cancer hit hard by deadly explosions in Beirut
por: Gourd, Elizabeth
Publicado: (2020)

Eye: The Hard-hit Victim of COVID-19 Pandemic
por: Gaur, Aman, et al.
Publicado: (2022)

Innervation in women with uterine myoma and adenomyosis
por: Choi, Ye Jin, et al.
Publicado: (2015)

Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
por: Li, Muzi, et al.
Publicado: (2021)

Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
por: Jain, Shikha, et al.
Publicado: (2016)

The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis
por: Harada, Tasuku, et al.
Publicado: (2023)

Hit hard in golden hours: thoughts on preventing the next pandemic
por: Kumar Garg, S.
Publicado: (2022)

Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment
por: Park, Chan Woo, et al.
Publicado: (2016)

Speech understanding in diffuse steady noise in typically hearing and hard of hearing listeners
por: Bestel, Julie, et al.
Publicado: (2022)

Laparoscopic Radiofrequency Thermal Ablation for Uterine Adenomyosis
por: Scarperi, Stefano, et al.
Publicado: (2015)

Infertility and Adenomyosis
por: Campo, Sebastiano, et al.
Publicado: (2012)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
por: Chwalisz, Kristof
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pmv04grk6ifc0dvalmemq8hi5a